Suppression of Epstein-Barr virus-encoded latent membrane protein-1 by RNA interference inhibits the metastatic potential of nasopharyngeal carcinoma cells

Biochemical and Biophysical Research Communications

Volumn 315, Issue 1, 2004, Pages 212-218

  Li, Xiang Ping ^a   Li, Gang ^a,b   Peng, Ying ^b   Kung, Hsiang Fu ^b   Lin, Marie C ^b  

^a FIRST MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Latent membrane protein 1; Metastasis; Nasopharyngeal carcinoma; Small hairpin RNA

Indexed keywords

LATENT MEMBRANE PROTEIN 1;

ARTICLE; CARCINOMA CELL; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; GENE REPRESSION; GENETIC CODE; METASTASIS; METASTASIS INHIBITION; NASOPHARYNX CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; VIRUS CARCINOGENESIS;

HUMAN HERPESVIRUS 4;

EID: 0842329646     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.01.045     Document Type: Article

References (37)

1. McDermott A.L., Dutt S.N., Watkinson J.C. The aetiology of nasopharyngeal carcinoma. Clin. Otolaryngol. 26:2001;82-92.
2. Yu M.C., Yuan J.M. Epidemiology of nasopharyngeal carcinoma. Semin. Cancer Biol. 12:2002;421-429.
3. Hu L.F., Chen F., Zheng X., Ernberg I., Cao S.L., Christensson B., Klein G., Winberg G. Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP1. Oncogene. 8:1993;1575-1583.
4. Pagano J.S. Epstein-Barr virus: the first human tumor virus and its role in cancer. Proc. Assoc. Am. Physicians. 111:1999;573-580.
5. Niedobitek G., Meru N., Delecluse H.J. Epstein-Barr virus infection and human malignancies. Int. J. Exp. Pathol. 82:2001;149-170.
6. Herrmann K., Niedobitek G. Epstein-Barr virus-associated carcinomas: facts and fiction. J. Pathol. 199:2003;140-145.
7. Pagano J.S. The Epstein-Barr virus and nasopharyngeal carcinoma. Cancer. 74:1994;2397-2398.
8. Pathmanathan R., Prasad U., Sadler R., Flynn K., Raab-Traub N. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N. Engl. J. Med. 333:1995;693-698.
9. Wakisaka N., Pagano J.S. Epstein-Barr virus induces invasion and metastasis factors. Anticancer Res. 23:2003;2133-2138.
10. Tsao S.W., Tramoutanis G., Dawson C.W., Lo A.K., Huang D.P. The significance of LMP1 expression in nasopharyngeal carcinoma. Semin. Cancer Biol. 12:2002;473-487.
11. Wang D., Liebowitz D., Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transformed established rodent cells. Cell. 43:1985;831-840.
12. Dawson C.W., Rickinson A.B., Young L.S. Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature. 344:1990;777-780.
13. Yoshizaki T. Promotion of metastasis in nasopharyngeal carcinoma by Epstein-Barr virus latent membrane protein-1. Histol. Histopathol. 17:2002;845-850.
14. Horikawa T., Yoshizaki T., Sheen T.S., Lee S.Y., Furukawa M. Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma. Cancer. 89:2000;715-723.
15. Horikawa T., Sheen T.S., Takeshita H., Sato H., Furukawa M., Yoshizaki T. Induction of c-Met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinoma. Am. J. Pathol. 159:2001;27-33.
16. Raab-Traub N., Flynn K., Klein C., Pizza G., De Vinci C., Occhiuzzi L., Farneti G., Caliceti U., Pirodda E. EBV-associated malignancies. J. Exp. Pathol. 3:1987;449-456.
17. Stetler-Stevenson W.G., Yu A.E. Proteases in invasion: matrix metalloproteinases. Semin. Cancer Biol. 11:2001;143-152.
18. Hui A.B., Cheung S.T., Fong Y., Lo K.W., Huang D.P. Characterization of a new EBV-associated nasopharyngeal carcinoma cell line. Cytogenetics. 101:1998;83-88.
19. Cheung S.T., Huang D.P., Hui A.B., Lo K.W., Ko C.W., Tsang Y.S., Wong N., Whitney B.M., Lee J.C. Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus. Int. J. Cancer. 83:1999;121-126.
20. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 411:2001;494-498.
21. Fire A., Xu S., Montgomery M.K., Kostas S.A. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 391:1998;806-811.
22. Zamore P.D. RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21-23 nucleotide intervals. Cell. 101:2000;25-33.
23. Paul C.P., Good P.D., Winer I., Engelke D.R. Effective expression of small interfering RNA in human cells. Nat. Biotechnol. 20:2002;505-508.
24. Brummelkamp T.R., Bernards R., Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science. 296:2002;550-553.
25. Zamore P.D. RNA interference: listening to the sound of silence. Nat. Struct. Biol. 8:2001;746-750.
26. Harborth J., Elbashir S.M., Bechert K., Tuschl T., Weber K. Identification of essential genes in cultured mammalian cells using small interfering RNAs. J. Cell Sci. 114:2001;4557-4565.
27. Tsao S.W., Liu Y., Wang X., Yuen P.W., Leung S.Y., Yuen S.T., Pan J., Nicholls J.M., Cheung A.L., Wong Y.C. The association of E-cadherin expression and the methylation status of the E-cadherin gene in nasopharyngeal carcinoma cells. Eur. J. Cancer. 39:2003;524-531.
28. Chen L., Segal D.M., Mash D.C. Semi-quantitative reverse-transcriptase polymerase chain reaction: an approach for the measurement of target gene expression in human brain. Brain Res. Protoc. 4:1999;132-139.
29. Jiang X.H., Wong C.Y., Lin C.M., Zhu G.H., Kung H.F., Jiang S.H., Yang D., Lam S.K. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells. Oncogene. 20:2001;8009-8018.
30. Grille S.J., Bellacosa A., Upson J. The protein kinase akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res. 63:2003;2172-2178.
31. Kassis J., Maeda A., Teramoto N., Takada K., Wu C., Klein G., Wells A. EBV-expressing AGS gastric carcinoma cell sublines present increased motility and invasiveness. Int. J. Cancer. 99:2002;644-651.
32. Wakisaka N., Murono S., Yoshizaki T., Furukawa M., Pagano J.S. Epstein-Barr virus latent membrane protein 1 induces and causes release of fibroblast growth factor-2. Cancer Res. 62:2002;6337-6344.
33. Kenney J.L., Guinness M.E., Curiel T., Lacy J. Antisense to the Epstein-Barr virus (EBV)-encoded latent membrane protein 1 (LMP-1) suppresses LMP-1 and bcl-2 expression and promotes apoptosis in EBV-immortalized B cells. Blood. 92:1998;1721-1727.
34. Noguchi T., Ikeda K., Yamamoto K., Yoshida I., Ashiba A., Tsuchiyama J., Shinagawa K., Yoshino T., Takata M., Harada M. Antisense oligodeoxynucleotides to latent membrane protein 1 induce growth inhibition, apoptosis and Bcl-2 suppression in Epstein-Barr virus (EBV)-transformed B-lymphoblastoid cells, but not in EBV-positive natural killer cell lymphoma cells. Br. J. Haematol. 114:2001;84-92.
35. Yoshizaki T., Sato H., Furukawa M., Pagano J.S. The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein-1. Proc. Natl. Acad. Sci. USA. 95:1998;3621-3626.
36. Horikawa T., Sheen T.S., Takeshita H., Sato H., Furukawa M., Yoshizaki T. Induction of c-Met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinoma. Am. J. Pathol. 159:2001;27-33.
37. Borkhardt A. Blocking oncogenes in malignant cells by RNA interference - new hope for a highly specific cancer treatment. Cancer Cell. 2:2002;167-168.